What does STERIMA do?

STERIMA is a cleaning company in Kortrijk. Public Limited, started on 2 June 1972, 1 establishment.

What is the address of STERIMA?

The registered office of STERIMA is located at Zonnekestraat(Bis) 13, 8501 Kortrijk.

Is STERIMA still active?

Yes. According to the CBE (29 October 2026) STERIMA is active, legal situation “Normale toestand”, started on 2 June 1972.

Is STERIMA registered on Peppol?

Yes, STERIMA is registered on the Peppol network with ID 0208:0412498042.

What is the enterprise number of STERIMA?

The enterprise number of STERIMA is BE0412498042.

When was STERIMA founded?

STERIMA was founded on 2 June 1972.

Who are the directors of STERIMA?

According to the 2025 annual accounts, the directors of STERIMA are: Pollet Medical Group NV, Smardix BESLOTEN VENNOOTSCHAP, eFlux BV.

Is STERIMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 June 1972; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did STERIMA make in 2025?

STERIMA posted a profit after taxes of € 689,299 in financial year 2025.

What is the revenue of STERIMA?

In its most recent annual accounts (2025), STERIMA reported revenue of € 12,232,565.

How much does an employee at STERIMA earn?

The average wage cost per full-time employee at STERIMA was € 63,900 in 2025: staff costs of € 3.4 million for 53.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does STERIMA have?

According to the 2025 annual accounts, STERIMA has 53.4 full-time equivalents (FTE).

STERIMA (Public Limited) - Kortrijk - BE0412498042

Dossier STERIMA, printed on 29 October 2026 from databakkes.be/en/0412498042/sterima. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

STERIMA from Kortrijk, company number BE0412498042, closed financial year 2025 with a result of € 689,299 after tax. For that financial year STERIMA recorded revenue of € 12.2 million and equity of € 6.8 million. Compared with financial year 2024, the result moved from € 657,045 to € 689,299. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.

What it is worth Healthy

€ 6.8 million

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 689,299

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 32,373

▼ 71% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 800,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

53.4

▼ 3.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 6.3 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 3.4 million

▲ 4% vs 2024

€ 63,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 192,878

▲ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 467,009

▲ 66% vs 2024

€ 56,895 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1.8 million

▼ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 79 days on average.

Taxes and wages

€ 981,855

▲ 74% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 11,204,364 Revenue 2022: € 11,204,364 First fiscal year in the series	€ 12,418,677 Revenue 2023: € 12,418,677 ▲ 11% vs 2022 (€ 11,204,364) Favourable step	€ 11,600,739 Revenue 2024: € 11,600,739 ▼ 7% vs 2023 (€ 12,418,677) Unfavourable step	€ 12,232,565 Revenue 2025: € 12,232,565 ▲ 5% vs 2024 (€ 11,600,739) Favourable step	▲ 5%
Profit after taxes	€ 4,792,563 Profit after taxes 2022: € 4,792,563 First fiscal year in the series	€ 1,080,428 Profit after taxes 2023: € 1,080,428 ▼ 77% vs 2022 (€ 4,792,563) Unfavourable step	€ 657,045 Profit after taxes 2024: € 657,045 ▼ 39% vs 2023 (€ 1,080,428) Unfavourable step	€ 689,299 Profit after taxes 2025: € 689,299 ▲ 5% vs 2024 (€ 657,045) Favourable step	▲ 5%
Equity	€ 8,182,026 Equity 2022: € 8,182,026 First fiscal year in the series	€ 9,262,454 Equity 2023: € 9,262,454 ▲ 13% vs 2022 (€ 8,182,026) Favourable step	€ 6,919,500 Equity 2024: € 6,919,500 ▼ 25% vs 2023 (€ 9,262,454) Unfavourable step	€ 6,808,799 Equity 2025: € 6,808,799 ▼ 2% vs 2024 (€ 6,919,500) Unfavourable step	▼ 2%
Total debts	€ 6,125,646 Total debts 2022: € 6,125,646 First fiscal year in the series	€ 4,141,416 Total debts 2023: € 4,141,416 ▼ 32% vs 2022 (€ 6,125,646) Favourable step	€ 6,240,399 Total debts 2024: € 6,240,399 ▲ 51% vs 2023 (€ 4,141,416) Unfavourable step	€ 4,102,874 Total debts 2025: € 4,102,874 ▼ 34% vs 2024 (€ 6,240,399) Favourable step	▼ 34%
Cash	€ 37,895 Cash 2022: € 37,895 First fiscal year in the series	€ 186,912 Cash 2023: € 186,912 ▲ € 149,017 vs 2022 (€ 37,895) Favourable step	€ 111,359 Cash 2024: € 111,359 ▼ 40% vs 2023 (€ 186,912) Unfavourable step	€ 32,373 Cash 2025: € 32,373 ▼ 71% vs 2024 (€ 111,359) Unfavourable step	▼ 71%
Retained profit	€ 8,057,026 Retained profit 2022: € 8,057,026 First fiscal year in the series	€ 9,137,454 Retained profit 2023: € 9,137,454 ▲ 13% vs 2022 (€ 8,057,026) Favourable step	€ 6,794,500 Retained profit 2024: € 6,794,500 ▼ 26% vs 2023 (€ 9,137,454) Unfavourable step	€ 6,683,799 Retained profit 2025: € 6,683,799 ▼ 2% vs 2024 (€ 6,794,500) Unfavourable step	▼ 2%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 3,000,000 Dividend 2024: € 3,000,000 Unchanged (€ 0) Unchanged	€ 800,000 Dividend 2025: € 800,000 ▼ 73% vs 2024 (€ 3,000,000) Unchanged	▼ 73%
Bank debt	€ 2,167,254 Bank debt 2022: € 2,167,254 First fiscal year in the series	€ 675,382 Bank debt 2023: € 675,382 ▼ 69% vs 2022 (€ 2,167,254) Favourable step	€ 281,727 Bank debt 2024: € 281,727 ▼ 58% vs 2023 (€ 675,382) Favourable step	€ 467,009 Bank debt 2025: € 467,009 ▲ 66% vs 2024 (€ 281,727) Unfavourable step	▲ 66%
Balance sheet total	€ 15,704,437 Balance sheet total 2022: € 15,704,437 First fiscal year in the series	€ 14,800,636 Balance sheet total 2023: € 14,800,636 ▼ 6% vs 2022 (€ 15,704,437) Unchanged	€ 14,431,710 Balance sheet total 2024: € 14,431,710 ▼ 2% vs 2023 (€ 14,800,636) Unchanged	€ 12,097,425 Balance sheet total 2025: € 12,097,425 ▼ 16% vs 2024 (€ 14,431,710) Unchanged	▼ 16%
Employees (FTE)	52.5 Employees (FTE) 2022: 52.5 First fiscal year in the series	56.5 Employees (FTE) 2023: 56.5 ▲ 4 vs 2022 (52.5) Unchanged	56.6 Employees (FTE) 2024: 56.6 ▲ 0.1 vs 2023 (56.5) Unchanged	53.4 Employees (FTE) 2025: 53.4 ▼ 3.2 vs 2024 (56.6) Unchanged	▼ 3.2

Key figures of STERIMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to STERIMA?

What happened at STERIMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Pollet Medical Group NV stepped down as director. NBB
2030 Smardix BESLOTEN VENNOOTSCHAP stepped down as director. NBB
2030 eFlux BV stepped down as director. NBB
Jul 16, 2026 New annual accounts for financial year 2025: profit of € 689,299 (▲ 5% vs 2024). Source: NBB ↗
2024 Pollet Medical Group NV became a director. NBB
2024 Smardix BESLOTEN VENNOOTSCHAP became a director. NBB
2024 eFlux BV became a director. NBB
Aug 1, 1972 New establishment in Kortrijk. KBO

In short

From € 4.8 million profit in 2022 to € 689,299 profit in 2025.

Paid € 962,214 in corporate taxes since 2022.

Best year ever: 2022, with € 4.8 million profit.

Paid out € 3.8 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Pollet Medical Group NV 100%

STERIMA

The shares are held by Pollet Medical Group NV (100%).

Directors

According to the 2025 annual accounts

Pollet Medical Group NV

Chairman of the board · represented by Sofie Pollet

Also active at: TERBASSENWEI, HEMOTECH BELUX, Sterima Medical & Logistic Services Liège, Integrated Service Solutions Hospitals

since 2024 · until 2030

Smardix BESLOTEN VENNOOTSCHAP

Managing director · represented by Taillieu Dimitri

Also active at: TERBASSENWEI, EURAQUA-EUROPE, UNIMID, PPG Belgium, ALTRANS, POLLET GROUP, MICRON, SUKO +14 more

since 2024 · until 2030

eFlux BV

Director · represented by Joos Verstraete

Also active at: FELIZAR, Sterima Medical & Logistic Services Liège

since 2024 · until 2030

Shareholders

Pollet Medical Group NV

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Zonnekestraat(Bis) 13

8501 Kortrijk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Integrated Service Solutions Hospitals same network

€ 2.6 million gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0412.498.042

VAT number

BE 0412.498.042

Registered office

Zonnekestraat(Bis) 13, 8501 Kortrijk

Names & denominations

STERIMA

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

2 June 1972

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Andere reinigingsactiviteiten

Activiteiten van industriële wasserijen

Vervaardiging van geneesmiddelen

View on CBE Public ↗ Annual accounts (NBB) ↗

STERIMA

Financials

What happened to STERIMA?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions